CytRx Corporation operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CytRx with three other
companies in this sector in the United States:
sales of $260,000.00
of which 100%
was Biological Product), and
Hemispherx Biopharma, Inc.
CytRx reported sales of $250,000.00
December of 2018.
increase of 150.0%
versus 2017, when the company's sales were $100,000.00 .